Diaphragmatic dysfunction in patients with chronic heart failure

Close metadata

OBJECTIVE

To detect diaphragmatic dysfunction in patients with chronic heart failure (CHF) via assessment of structural and functional state of external respiration.

MATERIAL AND METHODS

The study was conducted at the Almazov National Medical Research Center and included 58 subjects. There were 40 patients with CHF and 18 ones without CHF (control group). Inclusion criterion for the main group was CHF NYHA class II—IV. Exclusion criteria for both groups were pulmonary diseases, morbid obesity, abdominal diseases and anemia. We performed ultrasonic assessment of structural (thickness) and functional (thickening fraction and excursion) state of diaphragm under calm and deep inhalation/exhalation. External respiration was assessed using spirometry functions of a ventilator.

RESULTS

Patients with CHF had a thicker diaphragm on both sides and smaller volume of deep inhalation. Diaphragm thickening index was significantly less under deep inhalation on the right. Patients with CHF had a larger excursion of the right and left domes of the diaphragm under calm breathing, whereas no significant differences were found under deep breathing. We found a moderate positive linear correlation between CHF and diaphragm thickness on both sides under calm inhalation.

CONCLUSION

Structural and functional diaphragmatic dysfunction makes a contribution to respiratory failure in patients with CHF.

Keywords:

diaphragmatic dysfunction

chronic heart failure

sonography of diaphragm

diaphragm

lung function

diaphragmatic function

Authors:

Shabaev V.S.

Almazov National Medical Research Centre

ORCID: 0000-0002-5336-003X

Orazmagomedova I.V.

Almazov National Medical Research Centre

ORCID: 0000-0001-9629-4450

Mazurok V.A.

Almazov North-Western Federal Medical Research Center

SPIN RSCI: 6091-1102
Scopus AuthorID: 24475404300
ORCID: 0000-0003-3917-0771

Berezina A.V.

Almazov National Medical Research Center

ORCID: 0000-0002-5770-3845

Bautin A.E.

Almazov National Medical Research Center

SPIN RSCI: 9415-7300
Scopus AuthorID: 6601992723
ORCID: 0000-0001-5031-7637

Vasilyeva L.G.

Almazov National Medical Research Center

ORCID: 0000-0001-9611-9222

Aleksandrova D.A.

Almazov National Medical Research Center

ORCID: 0000-0002-0734-7344

Received:

03.05.2023

Accepted:

06.06.2023

List of references:

Paromov KV, Svirskii DA, Kirov MYu. Treatment option for diaphragm dysfunction after cardiac surgery: a review and a clinical case. Vestnik intensivnoj terapii im. A.I. Saltanova. 2022;3:57-68. (In Russ.). https://doi.org/10.21320/1818-474X-2022-3-57-68
Ukholkina GB. Oxygen therapy for cardiovascular diseases and COVID-19 infection. RMJ. 2020;11:14-18. (In Russ.).
Yaroshetskiy AI, Vlasenko AV, Gritsan AI, Kirov MYu, Kolesnichenko AP, Lebedinskii KM, Nikolaenko EM, Protsenko DN. Non-invasive respiratory support (the second edition). Clinical guidelines of the Federation of Anesthesiologists and Reanimatologists of Russia. Anesteziologiya i Reanimatologiya. 2019;6:5-19. (In Russ.). https://doi.org/10.17116/anaesthesiology20190615
Shvaiko SN. Clinical significance of the diagnosis of respiratory muscle dysfunction in patients with chronic obstructive pulmonary disease and chronic heart failure. Rossijskij mediko-biologicheskij vestnik im. akad. I.P. Pavlova. 2006;4:69-74. (In Russ.).
Miyagi M, Kinugasa Y, Sota T, Yamada K, Ishisugi T, Hirai M, Yanagihara K, Haruki N, Matsubara K, Kato M, Yamamoto K. Diaphragm Muscle Dysfunction in Patients With Heart Failure. Journal of Cardiac Failure. 2018;24(4):209-216. https://doi.org/10.1016/j.cardfail.2017.12.004
Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kübler W, Haass M. Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation. 2001;103(17):2153-2158. https://doi.org/10.1161/01.cir.103.17.2153
Solomonova LN, Storozhakov GV, Gendlin GE, Melekhov AV, Svetlakov VI. The state of the external respiratory system in patients with chronic heart failure. Rossijskij kardiologicheskij zhurnal. 2006;1:88-94. (In Russ.).
Shilov AM, Mel’nik MV, Chubarov MV, Grachev SP, Babchenko PK. Respiratory disorders in patients with chronic heart failure. RMZh. 2004;15:912. (In Russ.).
Kee K, Naughton MT. Heart failure and the lung. Circulation Journal. 2010;74(12):2507-2516. https://doi.org/10.1253/circj.cj-10-0869
Meyer FJ, Zugck C, Haass M, Otterspoor L, Strasser RH, Kübler W, Borst MM. Inefficient ventilation and reduced respiratory muscle capacity in congestive heart failure. Basic Research in Cardiology. 2000;95:333-342. https://doi.org/10.1007/s003950070053
Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050-1053. https://doi.org/10.1016/s0140-6736(96)07015-8
McParland C, Krishnan B, Wang Y, Gallagher CG. Inspiratory muscle weakness and dyspnea in chronic heart failure. The American Review of Respiratory Disease. 1992;146(2):467-472. https://doi.org/10.1164/ajrccm/146.2.467
Mancini DM, Henson D, LaManca J, Levine S. Respiratory muscle endurance is decreased in patients with heart failure. Circulation. 1992;86(Suppl I):IF515. https://doi.org/10.1161/01.cir.86.3.909
Andriopoulou M, Dimaki N, Kallistratos MS, Chamodraka E, Jahaj E, Vassiliou AG, Giokas G, Kotanidou A, Manolis AJ, Piepoli MF, Filippatos G. Skeletal muscle alterations and exercise intolerance in heart failure with preserved ejection fraction patients: ultrasonography assessment of diaphragm and quadriceps. European Journal of Heart Failure. 2022;24(4):729-731. https://doi.org/10.1002/ejhf.2462
Begrambekova YuL, Karanadze NA, Orlova YA. Alterations of the respiratory system in heart failure. Kardiologiya. 2019;59(2S):15-24. (In Russ.). https://doi.org/10.18087/cardio.2626
Aleksandrov AL, Perlei VE, Gichkin AYu, Surkova EG, Yakovleva NG, Kuzubova NA. The relationship of the functional state of the diaphragm with indicators of the function of external respiration in patients with COPD with severe and moderate course. Uchenye zapiski Pervogo Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova. 2012;19(3):66-69. (In Russ.).
Lakhin RE. Ul’trazvuk legkikh v ORIT pri COVID-19: uchebnoe posobie. 2-e izd., ispr. i dop. M.: Futuris Print; 2020. (In Russ.).
Nekludova GV, Avdeev SN. Possibilities of ultrasound research of the diaphragm. Terapevticheskij arkhiv. 2019;91(3):86-92. (In Russ.). https://doi.org/10.26442/00403660.2019.03.000129
Shabaev VS, Orazmagomedova IV, Mazurok VA, Berezina AV, Vasilyeva LG, Aleksandrova DA. Sonography indicators of diaphragm in healthy individuals. Anesteziologiya i Reanimatologiya. 2023;2:44-50. (In Russ.). https://doi.org/10.17116/anaesthesiology202302144
Santana PV, Cardenas LZ, Albuquerque ALP, Carvalho CRR, Caruso P. Diaphragmatic ultrasound: a review of its methodological aspects and clinical uses. Jornal Brasileiro de Pneumologia. 2020;46(6):e20200064. https://doi.org/10.36416/1806-3756/e20200064
Ueki J, De Bruin PF, Pride NB. In vivo assessment of diaphragm contraction by ultrasound in normal subjects. Thorax. 1995;50(11):1157-1161. https://doi.org/10.1136/thx.50.11.1157
Vu PH, Tran VD, Duong MC, Cong QT, Nguyen T. Predictive value of the negative inspiratory force index as a predictor of weaning success: a crosssectional study. Acute Critical Care. 2020;35(4):279-285. https://doi.org/10.4266/acc.2020.00598
Poole DC, Sexton WL, Farkas GA, Powers SK, Reid MB. Diaphragm structure and function in health and disease. Medicine and Science in Sports and Exercise. 1997;29(6):738-754. https://doi.org/10.1097/00005768-199706000-00003
Schepens T, Dres M, Heunks L, Goligher E. Diaphragm-protective mechanical ventilation. Current Opinion in Critical Care. 2018;25(1):77-85. https://doi.org/10.1097/MCC.0000000000000578
Teplyakov AT, Kalyuzhin VV, Kalyuzhina EV, Chernogoryuk GE, Rachkovsky MI, Bespalova ID, Terentyeva NN, Livshits IK, Solovtsov MA, Chernyavskaya GM. Pathology of the peripheral circulation in chronic heart failure. Byulleten’ sibirskoj meditsiny. 2017;16(1):162-178. (In Russ.). https://doi.org/10.20538/1682-0363-2017-1-162-178
Spiesshoefer J, Henke C, Kabitz HJ, Bengel P, Schütt K, Nofer JR, Spieker M, Orwat S, Diller GP, Strecker JK, Giannoni A, Dreher M, Randerath WJ, Boentert M, Tuleta I. Heart Failure Results in Inspiratory Muscle Dysfunction Irrespective of Left Ventricular Ejection Fraction. Respiration. 2021;100(2):96-108. https://doi.org/10.1159/000509940
Urazova GE, Landyshev YuS, Tseluiko SS, Krasavina NP. Influence of chronic respiratory insufficiency on morfofunctional condition of the diaphragm muscle. Byulleten’ fiziologii i patologii dykhaniya. 2007;26:32-35. (In Russ.).
Shabaev VS, Orazmagomedova IV, Mazurok VA, Berezina AV, Vasilyeva LG, Aleksandrova DA. Sonography indicators of diaphragm and their correlation with spirometry data in healthy individuals:clinical study. Vestnik intensivnoj terapii im. A.I. Saltanova. 2023;2:91-101. (In Russ.). https://doi.org/10.21320/1818-474X-2023-2-91-101
Carrié C, Bonnardel E, Vally R, Revel P, Marthan R, Marthan R. Impairment due to Neuromuscular Disease and its Correlation with Diaphragmatic Ultrasound: A Preliminary Study. Ultrasound in Medicine and Biology. 2016;42(1):143-149. https://doi.org/10.1016/j.ultrasmedbio.2015.09.020

Merz TM, Regli B, Rothen HU, Felleiter P. Propofol infusion syndrome: a fatal case at a low infusion rate. Anesthesia and Analgesia. 2006;103(4):1050. https://doi.org/10.1213/01.ane.0000239080.82501.c7

Chukwuemeka A, Ko R, Ralph-Edwards A. Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anesthesia and Intensive Care. 2006;34(5):651-655. https://doi.org/10.1177/0310057X0603400503

Roberts RJ, Barletta JF, Fong JJ, Schumaker G, Kuper PJ, Papadopoulos S, Yogaratnam D, Kendall E, Xamplas R, Gerlach AT, Szumita PM, Anger KE, Arpino PA, Voils SA, Grgurich P, Ruthazer R, Devlin JW.Incidence of propofol-related infu- sion syndrome in critically ill adults: A prospective, multicenter study. Critical Care. 2009;13(5):169. https://doi.org/10.1186/cc8145

Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E. A double-blind, randomized comparison of i.v.lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology. 2001;95(2):286-298. https://doi.org/10.1097/00000542-200108000-00007

Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Critical Care Medicine. 1998;26(5):947-956. https://doi.org/10.1097/00003246-199805000-00034

Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Population pharmacodynamics modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients. European Journal of Clinical Pharmacology. 2006;62(3):185-194. https://doi.org/10.1007/s00228-005-0085-8

Swart EL, de Jongh J, Zuideveld KP, Danhof M, Thijs LG, Strack van Schijndel RJ. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous veno-venous hemofiltration. American Journal of Kidney Diseases. 2005;45(2):360-371. https://doi.org/10.1053/j.ajkd.2004.09.004

Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. British Journal of Clinical Pharmacology. 2004;57(2):145. https://doi.org/10.1046/j.1365-2125.2003.01957.x

Ariano RE, Kassum DA, Aronson KJ. Comparison of sedative recovery time after midazolam versus diazepam administration. Critical Care Medicine. 1994;22(9):1492-1496. https://doi.org/10.1097/00003246-199409000-00022

Garcia R, Salluh JIF, Andrade TR, Farah D, da Silva PSL, Bastos DF, Fonseca MCM. A systematic review and meta-analysis of propofol versus midazolam sedation in adult intensive care (ICU) patients. Journal of Critical Care. 2021;64:91-99. https://doi.org/10.1016/j.jcrc.2021.04.001

Buckley MS, Smithburger PL, Wong A, Fraser GL, Reade MC, Klein-Fedyshin M. Dexmedetomidine for facilitating mechanical ventilation extubation in difficult-to-wean ICU patients: systematic review and meta-analysis of clinical trials. Journal of Intensive Care Medicine. 2020;6:885066620937673. https://doi.org/10.1177/0885066620937673

Chen P, Jiang J, Zhang Y, Li G, Qiu Z, Levy MM, Hu B. Effect of dexmedetomidine on duration of mechanical ventilation in septic patients: a systematic review and meta-analysis. BMC Pulmonary Medicine. 2020;20(1):42. https://doi.org/10.1186/s12890-020-1065-6

Hughes CG, Mailloux PT, Devlin JW, Swan JT, Sanders RD, Anzueto A, Jackson JC, Hoskins AS, Pun BT, Orun OM, Raman R, Stollings JL, Kiehl AL, Duprey MS, Bui LN, O’Neal HR Jr, Snyder A, Gropper MA, Guntupalli KK, Stashenko GJ, Patel MB, Brummel NE, Girard TD, Dittus RS, Bernard GR, Ely EW, Pandharipande PP; MENDS2 Study Investigators. Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis. New England Journal of Medicine. 2021;384(15):1424-1436. https://doi.org/10.1056/NEJMoa2024922

Heybati K, Zhou F, Ali S, Deng J, Mohananey D, Villablanca P, Ramakrishna H. Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a systematic review and meta-analysis of randomised controlled trials. British Journal of Anaesthesia. 2022;129(4):515-526. https://doi.org/10.1016/j.bja.2022.06.020

Patel SB, Kress JP. Sedation and Analgesia in the Mechanically Ventilated Patient. American journal of respiratory and Critical Care Medicine. 2012;185(5):486-497. https://doi.org/10.1164/rccm.201102-0273CI

Zhou Y, Jin X, Kang Y, Liang G, Liu T, Deng N. Midazolam and propofol used alone or sequentially for long-term sedation in critically ill, mechanically ventilated patients: A prospective, randomized study. Critical Care. 2014;18(3):R122. https://doi.org/10.1186/cc13922

Casault C, Soo A, Lee CH. Sedation strategy and ICU delirium: a multicentre, population-based propensity score-matched cohort study. BMJ Open. 2021;11:e045087. https://doi.org/10.1136/bmjopen-2020-045087

Huey-Ling L, Chun-Che S, Jen-Jen T, Shau-Ting L, Hsing-I C. Comparison of the effect of protocol-directed sedation with propofol vs. Midazolam by nurses in intensive care: Efficacy, haemodynamic stability and patient satisfaction. Journal of Clinical Nursing. 2008;17(11):1510-1517. https://doi.org/10.1111/j.1365-2702.2007.02128.x

Mesnil M, Capdevila X, Bringuier S, Trine PO, Falquet Y, Charbit J, Roustan JP, Chanques G, Jaber S. Long-term sedation in intensive care unit: A randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Medicine. 2011;37(6):933-941. https://doi.org/10.1007/s00134-011-2187-3

Srivastava VK, Agrawal S, Kumar S, Mishra A, Sharma S, Kumar R. Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients. Journal of Clinical and Diagnostic Research. 2014;8:GC04GC07. https://doi.org/10.7860/JCDR/2014/8797.4817

Kawazoe Y, Miyamoto K, Morimoto T, Yamamoto T, Fuke A, Hashimoto A, Koami H, Beppu S, Katayama Y, Itoh M, Ohta Y, Yamamura H; Dexmedetomidine for Sepsis in Intensive Care Unit Randomized Evaluation (DESIRE) Trial Investigators. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis a randomized clinical trial. JAMA. 2017;317(13):1321-1327. https://doi.org/10.1001/jama.2017.2088

Reade MC, Eastwood GM, Bellomo R, Bailey M, Bersten A, Cheung B, Davies A, Delaney A, Ghosh A, van Haren F, Harley N, Knight D, McGuiness S, Mulder J, O’Donoghue S, Simpson N, Young P; DahLIA Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial. JAMA. 2016;315(14):1460-1468. https://doi.org/10.1001/jama.2016.2707

Farina N, Alaniz C. Reconsidering Dexmedetomidine for Sedation in the Critically Ill: Implications of the SPICE III Trial. Annals of Pharmacotherapy. 2020;54(5):504-508. https://doi.org/10.1177/1060028019890672

Møller MH, Alhazzani W, Lewis K, Belley-Cote E, Granholm A, Centofanti J, McIntyre WB, Spence J, Al Duhailib Z, Needham DM, Evans L, Reintam Blaser A, Pisani MA, D’Aragon F, Shankar-Hari M, Alshahrani M, Citerio G, Arora RC, Mehta S, Girard TD, Ranzani OT, Hammond N, Devlin JW, Shehabi Y, Pandharipande P, Ostermann M. Use of dexmedetomidine for sedation in mechanically ventilated adult ICU patients: a rapid practice guideline. Intensive Care Medicine. 2022;48(7):801-810. https://doi.org/10.1007/s00134-022-06660-x

Mulkey MA, Everhart DE. Sedation selection to reduce delirium risk: Why dexmedetomidine may be a better choice. Journal of the American Association of Nurse Practitioners. 2020;33(4):266-270. https://doi.org/10.1097/JXX.0000000000000364

Nelson KM, Patel GP, Hammond DA. Effects from continuous infusions of dexmedetomidine and propofol on hemodynamic stability in critically ill adult patients with septic shock. Journal of Intensive Care Medicine. 2020:35(9):875-880. https://doi.org/10.1177/0885066618802269

Chang YF, Chao A, Shih PY, Hsu YC, Lee CT, Tien YW, Yeh YC, Chen LW; NTUH Center of Microcirculation Medical Research (NCMMR). Comparison of dexmedetomidine versus propofol on hemodynamics in surgical critically ill patients. The Journal of Surgical Research. 2018;228:194-200. https://doi.org/10.1016/j.jss.2018.03.040

Owusu KA, Kurczewski L, Armahizer MJ, Zichichi A, Maciel CB, Heavner MS. DEXmedetomidine compared to PROpofol in NEurocritical Care [DEXPRONE]: A multicenter retrospective evaluation of clinical utility and safety. Journal of Critical Care. 2020;60:79-83. https://doi.org/10.1016/j.jcrc.2020.07.021

Wang G, Niu J, Li Z, Lv H, Cai H. The efficacy and safety of dexmedetomidine in cardiac surgery patients: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0202620. https://doi.org/10.1371/journal.pone.0202620

Lin Y, He B, Chen J, Wang Z. Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? A meta-analysis. Critical Care. 2012;16(5):R169. https://doi.org/10.1186/cc11646

Brock L. Dexmedetomidine in Adult Patients in Cardiac Surgery Critical Care: An Evidence-Based Review. AACN Advanced Critical Care. 2019;30(3):259-268. https://doi.org/10.4037/aacnacc2019888

Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50(3):206-217. https://doi.org/10.1176/appi.psy.50.3.206

Djaiani G, Silverton N, Fedorko L, Carroll J, Styra R, Rao V, Katznelson R. Dexmedetomidine versus propofol sedation reduces delirium after cardiac surgery: a randomized controlled trial. Anesthesiology. 2016;124(2):362-368. https://doi.org/10.1097/ALN.0000000000000951

Smithburger PL, Patel MK. Pharmacologic Considerations Surrounding Sedation, Delirium, and Sleep in Critically Ill Adults: A Narrative Review. Journal of Pharmacy Practice. 2019;32(3):271-291. https://doi.org/10.1177/0897190019840120

Allam MG. Dexmedetomidine versus midazolam for sedation of critically ill patients on noninvasive mechanical ventilation. Ain-Shams Journal of Anaesthesiology. 2016;9(2):178-185. https://doi.org/10.4103/1687-7934.179910

Huang Z, Chen YS, Yang ZL, Liu JY. Dexmedetomidine versus midazolam for the sedation of patients with noninvasive ventilation failure. Internal Medicine. 2012;51(17):2299-2305. https://doi.org/10.2169/internalmedicine.51.7810

Karim HM, Šarc I, Calandra C, Spadaro S, Mina B, Ciobanu LD, Gonçalves G, Caldeira V, Cabrita B, Perren A, Fiorentino G, Utku T, Piervincenzi E, El-Khatib M, Alpay N, Ferrari R, Abdelrahim ME, Saeed H, Madney YM, Harb HS, Vargas N, Demirkiran H, Bhakta P, Papadakos P, Gómez-Ríos MÁ, Abad A, Alqahtani JS, Hadda V, Singha SK, Esquinas AM. Role of Sedation and Analgesia during Noninvasive Ventilation: Systematic Review of Recent Evidence and Recommendations. Indian Journal of Critical Care Medicine. 2022;26(8):938-948. https://doi.org/10.5005/jp-journals-10071-23950

De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology. 2004;101(2):299-310. https://doi.org/10.1097/00000542-200408000-00009

Hellström J, Öwall A, Bergström J, Sackey PV. Cardiac outcome after sevoflurane versus propofol sedation following coronary bypass surgery: a pilot study. Acta Anaesthesiologica Scandinavica. 2011;55(4):460-467. https://doi.org/10.1111/j.1399-6576.2011.02405.x

Soro M, Gallego L, Silva V, Ballester MT, Lloréns J, Alvariño A, García-Perez ML, Pastor E, Aguilar G, Martí FJ, Carratala A, Belda FJ. Sevoflurane and propofol during anaesthesia and the postoperative period in coronary bypass graft surgery: a double- blind randomised study. European Journal of Anaesthesiology. 2012;29(12):561-569. https://doi.org/10.1097/EJA.0b013e3283560aea

Bellgardt M, Bomberg H, Herzog-Niescery J, Dasch B, Vogelsang H, Weber TP, Steinfort C, Uhl W, Wagenpfeil S, Volk T, Meiser A. Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients. European Journal of Anaesthesiology. 2015;32(1):6-13. https://doi.org/10.1097/EJA.0000000000000252

Soro M, Belda FJ, Badenes R, Alcantara MJ. Use of the AnaConDa (Anestesia Conserving Device) with sevoflurane in critical care patients. European Journal of Anaesthesiology. 2004;21(Suppl 32):708. https://doi.org/10.1097/00003643-200406002-00631

Jerath A, Beattie SW, Chandy T, Karski J, Djaiani G, Rao V, Yau T, Wasowicz M. Volatile-based short-term sedation in cardiac surgical patients: a prospective randomized controlled trial. Critical Care Medicine. 2015;43(5):1062-1069. https://doi.org/10.1097/CCM.0000000000000938

Martin J, Heymann A, Bäsell K, Baron R, Biniek R, Bürkle H, Dall P, Dictus C, Eggers V, Eichler I, Engelmann L, Garten L, Hartl W, Haase U, Huth R, Kessler P, Kleinschmidt S, Koppert W, Kretz FJ, Laubenthal H, Marggraf G, Meiser A, Neugebauer E, Neuhaus U, Putensen C, Quintel M, Reske A, Roth B, Scholz J, Schröder S, Schreiter D, Schüttler J, Schwarzmann G, Stingele R, Tonner P, Tränkle P, Treede RD, Trupkovic T, Tryba M, Wappler F, Waydhas C, Spies C. Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care — short version. German Medical Science. 2010;8:Doc02. https://doi.org/10.3205/000091

Kim HY, Lee JE, Kim HY, Kim J. Volatile sedation in the intensive care unit:A systematic review and meta-analysis. Medicine. 2017;96(49):e8976. https://doi.org/10.1097/MD.0000000000008976

Meiser A, Volk T, Wallenborn J, Guenther U, Becher T, Bracht H, Schwarzkopf K, Knafelj R, Faltlhauser A, Thal SC, Soukup J, Kellner P, Drüner M, Vogelsang H, Bellgardt M, Sackey P; Sedaconda study group. Inhaled isofurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial. The Lancet. Respiratory Medicine. 20219(11):1231-1240. https://doi.org/10.1016/S2213-2600(21)00323-4

Blondonnet R, Balde A, Zhai R, Pereira B, Futier E, Bazin J-E, Use of volatile anesthetics for sedation in the ICU during the COVID-19 pandemic: A national survey in France (VOL’ICU 2 study). PLoS One. 2022;17(12):e0278090. https://doi.org/10.1371/journal.pone.0278090

Fraser GL, Devlin JW, Worby CP, Alhazzani W, Barr J, Dasta JF, Kress JP, Davidson JE, Spencer FA. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Critical Care Medicine. 2013;41(9):30-38. https://doi.org/10.1097/CCM.0b013e3182a16898

Jung S, Na S, Kim HB, Joo HJ, Kim J. Inhalation sedation for postoperative patients in the intensive care unit: initial sevoflurane concentration and comparison of opioid use with propofol sedation. Acute Critical Care. 2020;35(3):197-204. https://doi.org/10.4266/acc.2020.00213

Jerath A, Slessarev M. The impact of the coronavirus pandemic on sedation in critical care: volatile anesthetics in the ICU. Current Opinion in Critical Care. 2023;29(1):14-18. https://doi.org/10.1097/MCC.0000000000001011

Burov NE. Ideas about the mechanism of anesthetic and therapeutic properties of xenon. Anesteziologiya i Reanimatologiya. 2011;2:58-62. (In Russ.).

Stryapko NV, Sazontova TG, Potievskaya VI, Molchanov IV. Adaptive effect of repeated use of xenon. Obshchaya reanimatologiya. 2014;10(2):50-56. (In Russ.).

Liu W, Liu Y, Chen H, Liu K, Tao H, Sun X. Xenon preconditioning: molecular mechanisms and biological effects. Medical Gas Research. 2013;3(1):3. https://doi.org/10.1186/2045-9912-3-3

Molchanov IV, Potievskaya VI, Pulina NN, Shebzukhova EKh. Treatment of patients with acute coronary syndrome by xenon inhalation. Doctor.Ru. 2012;10(78):35-40. (In Russ.).

Lakhin RE, Andreenko AA, Vlasenko AV, Martynov DV, Lazarev VV, Ovezov AM, Gorbachev VI, Leiderman IN, Belkin AA, Fischer VV, Lomivorotov VV, Kuzkov VV, Shifman EM, Grigoriev EV, Popov AS, Magomedov MA, Yaroshetsky AI. Modified Delphic analysis of the provisions and quality criteria of methodological recommendations «Sedation of patients in departments of anesthesiology, intensive care and intensive care». Vestnik intensivnoj terapii im. A.I. Saltanova. 2023;(2):45-54. (In Russ.). https://doi.org/10.21320/1818-474X-2023-2-45-54

Close metadata